 BioSpecifics Technologies Corp. NASDAQ: BSTC the Company, a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX in North America, today announced the appointment of Alex Monteith as Senior Vice President and Chief Business Officer. 